CURE recently visited Jersey Shore University Medical Center in Neptune, NJ to speak with Dr. Gregory Tiesi about Trans ...
The U.S. Food and Drug Administration (FDA) has granted traditional full approval to the CAR-T cell therapy Tecartus ...
That choice was not available to me. My perspective on genetic risk isn't theoretical. My mother, Ioanna, died when I was 9.
A study led by researchers at a community hospital in Sapporo, Japan found that comprehensive genomic testing using a ...
Author and survivor Parul Somani shares how patients with breast cancer can find peace of mind when clinical certainty is ...
Dr. Coleman: For patients with recurrent ovarian cancer, the main benefit of adding Lifyorli to nab-paclitaxel is controlling ...
New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...
U.S. Food and Drug Administration (FDA) has approved a PD-L1 companion diagnostic test for patients with esophageal cancer or ...
The study's safety findings suggest that the physical "number" of a patient's age is less important than their functional ...
CTIM-76 has received FDA fast track designation for platinum-resistant ovarian cancer, a step aimed at accelerating ...
In this segment, Dr. Gregory Vidal outlines what a typical first-line treatment plan looks like for patients with ER-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results